Peer-reviewed journal articles (187)
134.
Brion, J. P., smith, C., Couck, A. M., Gallo, J. M., & Anderton, B. (1993). Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. Journal of neurochemistry, 61(6), 2071-2080. doi:10.1111/j.1471-4159.1993.tb07444.x136.
Brion, J. P., Couck, A. M., Robertson, J. F. R., Loviny, T. L., & Anderton, B. (1993). Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament-tau in Alzheimer's disease. Journal of neurochemistry, 60(4), 1372-1382. doi:10.1111/j.1471-4159.1993.tb03298.x137.
Hanger, D., Hughes, K., Woodgett, J. R., Brion, J. P., & Anderton, B. (1992). Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neuroscience letters, 147(1), 58-62. doi:10.1016/0304-3940(92)90774-2143.
Hanger, D., Brion, J. P., Gallo, J. M., Cairns, N. J., Luthert, P. J., & Anderton, B. (1991). Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated. Biochemical journal, 275 ( Pt 1), 99-104.144.
Brion, J. P., Couck, A. M., Bruce, M., Anderton, B., & Flament Durand, J. (1991). Synaptophysin and chromogranin A immunoreactivities in senile plaques of Alzheimer's disease. Brain research, 539(1), 143-150. doi:10.1016/0006-8993(91)90697-T